Detection of free circulating Epstein-Barr virus DNA in plasma of patients with Hodgkin's disease

Sao Paulo Medical Journal

Volumn 124, Issue 3, 2006, Pages 154-157

  Musacchio, Juliane Garcez ^a,b,c   da Costa Carvalho, Maria da Glória ^a   de Morais, José Carlos Oliveira ^a,b   Silva, Nathalie Henriques ^a   Scheliga, Adriana ^a,d   Romano, Sérgio ^a,d   Spector, Nelson ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Hospital Universitario   (Brazil)

^c Universidade Federal do Rio de Janeiro ^*  (Brazil)

^d INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

DNA; Epstein Barr virus; Hodgkin disease; Lymphoma; Polymerase chain reaction

Indexed keywords

LATENT MEMBRANE PROTEIN 1; VIRUS DNA;

ADULT; ADVANCED CANCER; ARTICLE; BLOOD ANALYSIS; BRAZIL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC KIT; DNA DETERMINATION; EPSTEIN BARR VIRUS; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; KAPPA STATISTICS; LYMPH NODE METASTASIS; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; PROTEIN EXPRESSION;

EID: 33748874073     PISSN: 15163180     EISSN: 15163180     Source Type: Journal    
DOI: 10.1590/s1516-31802006000300009     Document Type: Article

References (22)

1. Glser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer. 1999;70(4):375-82.
2. Weiss LM, Strickler JG, Warnke R, Purtilo DT, Sklar J. Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol. 1987;129(1):86-91.
3. Huen DS, Henderson SA, Croom-Carter D, Rowe M. The Epstein-Barr virus latent membrane protein-1 (LMP-1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene. 1995;10(3):549-60.
4. Anker P, Mulcahy H. Chen XQ, Stroun M. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev. 1999;18(1):65-73.
5. Yamamoto M, Kimura H, Hironaka T, et al. Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated disease. J Clin Microbiol. 1995;33(7):1765-8.
6. Lo YM, Chan LY, Chan AT, et al. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res. 1999;59(21):5452-5.
7. Lei KI, Chan LY, Chan WY, Johnson PJ, Lo YM. Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphomaa. Clin Cancer Res, 2002;8(1):29-34.
8. Limaye AP, Huang ML, Atienza EE, Ferrenberg JM, Corey L. Detection of Epstein-Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders. J Clin Microbiol. 1999;37(4):1113-6.
9. Gallagher A. Armstrong AA, MacKenzie J, et al. Detection of Epstein-Barr virus (EBV) gcnomes in the serum of patients with EBV-associated Hodgkin's disease. Int J Cancer. 1999;84(4):442-8.
10. Lei KI, Chan LY, Chan WY, Johnson PJ, Lo YM. Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies. Br J Haematol. 2000;111(1):239-46.
11. Wagner HJ, Schlager F, Claviez A. Bucsky P. Detection of Epstein-Barr virus DNA in peripheral blood of paediatric patients with Hodgkin's disease by real-time polymerase chain reaction. Eur J Cancer. 2001;37(15):1853-7.
12. Rowe M, Evans HS, Young LS, Hennessy K, Kieff E, Rickinson AB. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. J Gen Virol. 1987;68(Pt 6):1575-86.
13. Deacon EM, Matthews JB, Potts AJ, Hamburger J, Bevan IS, Young LS. Detection of Epstein-Barr virus antigens and DNA in major and minor salivary glands using immunocytochemistry and polymerase chain reaction: possible relationship with Sjogren's syndrome. J Pathol. 1991;163(4):351-60.
14. Gulley ML, Glaser SL, Craig FE, et al. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma. Am J Clin Pathol. 2002;117(2):259-67.
15. Kornacker M, Jox A, Vockcrodt M, et al. Detection of a Hodgkin/ Reed-Sternberg cell specific immunoglobulin gene rearrangement in the serum DNA of a patient with Hodgkin's disease. Br J Haematol. 1999;106(2):528-31.
16. Audouin J, Diebold J, Pallensen G. Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients. J Pathol. 1992;167(4):381-4.
17. Herndier BG, Sanchez HC, Chang KL, Chen YY, Weiss LM. High prevalence of Epstein-Barr virus in Reed-Sternberg cells of HIV-associated Hodgkin's disease. Am J Pathol. 1993;142(4):1073-9.
18. Fan H, Kim SC, Chima CO. Epstein-Barr load as a marker of lymphoma in AIDS patients. J Med Virol. 2005;75(1):59-69.
19. Lo YM, Chan LY. Lo KW, et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res. 1999;59(6):1188-91.
20. Shotelersuk K, Khorprasert C, Sakdikul S, Pornthanakasem W, Voravud N, Mutiranga A. Epstein-Barr virus DNA in serum/plasma as a tumor market for nasopharyngeal cancer. Clin Cancer Res. 2000;6(3):1046-51.
21. Wagner HJ, Wessel M, Jabs W, et al. Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load using real-time quantitative polymerase chain reaction. Transplantation. 2001;72(6):1012-9.
22. Lin L, Yang J, Levi L, et al. Viral DNA in serum and plasma of patient with Epstein-Barr (EBV)-associated Hodgkin's lymphoma my be tumor derived and appears years before diagnosis. In: 44th Annual Meeting of the American Society of Hematology: 2002 Dec 6-10. Philadelphia: American Society of Hematology; 2002. [abstract 753].